What does APOTHEEK VANDEWALLE do?

APOTHEEK VANDEWALLE is a pharmacy in Gent. Public Limited, started on 6 December 2000, 1 establishment.

What is the address of APOTHEEK VANDEWALLE?

The registered office of APOTHEEK VANDEWALLE is located at Sint-Pietersaalststraat 13, 9000 Gent.

Is APOTHEEK VANDEWALLE still active?

Yes. According to the CBE (29 October 2026) APOTHEEK VANDEWALLE is active, legal situation “Normale toestand”, started on 6 December 2000.

Is APOTHEEK VANDEWALLE registered on Peppol?

Yes, APOTHEEK VANDEWALLE is registered on the Peppol network with ID 0208:0473438093.

What is the enterprise number of APOTHEEK VANDEWALLE?

The enterprise number of APOTHEEK VANDEWALLE is BE0473438093.

When was APOTHEEK VANDEWALLE founded?

APOTHEEK VANDEWALLE was founded on 6 December 2000.

Who are the directors of APOTHEEK VANDEWALLE?

According to the 2025 annual accounts, the directors of APOTHEEK VANDEWALLE are: Isabelle Vandewalle, Vanram.

Is APOTHEEK VANDEWALLE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2000; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VANDEWALLE make in 2025?

APOTHEEK VANDEWALLE recorded a loss after taxes of € 2,930 in financial year 2025.

What is the revenue of APOTHEEK VANDEWALLE?

As a small company, APOTHEEK VANDEWALLE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 18,595.

How much does an employee at APOTHEEK VANDEWALLE earn?

The average wage cost per full-time employee at APOTHEEK VANDEWALLE was € 71,000 in 2022: staff costs of € 70,961 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VANDEWALLE have?

According to the 2025 annual accounts, APOTHEEK VANDEWALLE has 0 full-time equivalents (FTE).

APOTHEEK VANDEWALLE (Public Limited) - Gent

Dossier APOTHEEK VANDEWALLE, printed on 29 October 2026 from databakkes.be/en/0473438093/apotheek-vandewalle. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Shrinking team NBB

FTE fell two years in a row, from 0.8 to 0.

Financials

Financial year 2025

APOTHEEK VANDEWALLE from Gent, company number BE0473438093, closed financial year 2025 with a result of € -2,930 after tax. For that financial year APOTHEEK VANDEWALLE recorded a gross margin of € 18,595 and equity of € 336,654. Compared with financial year 2024, the result moved from € -16,991 to € -2,930. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 336,654

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2,930

▲ 83 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,495

▲ 119% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 274,681.

People and assets in 2025

Full-time equivalents

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 6,822

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 40,535

▲ 117% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,093

▼ 86% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 142,013 Gross margin 2022: € 142,013 First fiscal year in the series	€ 94,492 Gross margin 2023: € 94,492 ▼ 33% vs 2022 (€ 142,013) Unfavourable step	€ 64,330 Gross margin 2024: € 64,330 ▼ 32% vs 2023 (€ 94,492) Unfavourable step	€ 18,595 Gross margin 2025: € 18,595 ▼ 71% vs 2024 (€ 64,330) Unfavourable step	▼ 71%
Profit after taxes	€ 31,927 Profit after taxes 2022: € 31,927 First fiscal year in the series	€ 5,302 Profit after taxes 2023: € 5,302 ▼ 83% vs 2022 (€ 31,927) Unfavourable step	€ -16,991 Profit after taxes 2024: € -16,991 ▼ € 22,293 vs 2023 (€ 5,302) Unfavourable step	€ -2,930 Profit after taxes 2025: € -2,930 ▲ € 14,061 vs 2024 (€ -16,991) Favourable step	▲ € 14,061
Equity	€ 351,273 Equity 2022: € 351,273 First fiscal year in the series	€ 356,575 Equity 2023: € 356,575 ▲ 2% vs 2022 (€ 351,273) Favourable step	€ 339,584 Equity 2024: € 339,584 ▼ 5% vs 2023 (€ 356,575) Unfavourable step	€ 336,654 Equity 2025: € 336,654 ▼ 1% vs 2024 (€ 339,584) Unfavourable step	▼ 1%
Total debts	€ 121,946 Total debts 2022: € 121,946 First fiscal year in the series	€ 97,022 Total debts 2023: € 97,022 ▼ 20% vs 2022 (€ 121,946) Favourable step	€ 97,196 Total debts 2024: € 97,196 Unchanged (€ 97,022) Unfavourable step	€ 105,767 Total debts 2025: € 105,767 ▲ 9% vs 2024 (€ 97,196) Unfavourable step	▲ 9%
Cash	€ 42,425 Cash 2022: € 42,425 First fiscal year in the series	€ 9,298 Cash 2023: € 9,298 ▼ 78% vs 2022 (€ 42,425) Unfavourable step	€ 13,497 Cash 2024: € 13,497 ▲ 45% vs 2023 (€ 9,298) Favourable step	€ 29,495 Cash 2025: € 29,495 ▲ 119% vs 2024 (€ 13,497) Favourable step	▲ 119%
Land & buildings	€ 246,611 Land & buildings 2022: € 246,611 First fiscal year in the series	€ 228,306 Land & buildings 2023: € 228,306 ▼ 7% vs 2022 (€ 246,611) Unchanged	€ 210,001 Land & buildings 2024: € 210,001 ▼ 8% vs 2023 (€ 228,306) Unchanged	€ 191,697 Land & buildings 2025: € 191,697 ▼ 9% vs 2024 (€ 210,001) Unchanged	▼ 9%
Retained profit	€ 289,300 Retained profit 2022: € 289,300 First fiscal year in the series	€ 294,602 Retained profit 2023: € 294,602 ▲ 2% vs 2022 (€ 289,300) Favourable step	€ 277,611 Retained profit 2024: € 277,611 ▼ 6% vs 2023 (€ 294,602) Unfavourable step	€ 274,681 Retained profit 2025: € 274,681 ▼ 1% vs 2024 (€ 277,611) Unfavourable step	▼ 1%
Bank debt	€ 6,386 Bank debt 2022: € 6,386 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 6,386) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 519,081 Balance sheet total 2022: € 519,081 First fiscal year in the series	€ 499,460 Balance sheet total 2023: € 499,460 ▼ 4% vs 2022 (€ 519,081) Unchanged	€ 482,643 Balance sheet total 2024: € 482,643 ▼ 3% vs 2023 (€ 499,460) Unchanged	€ 488,284 Balance sheet total 2025: € 488,284 ▲ 1% vs 2024 (€ 482,643) Unchanged	▲ 1%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	0.8 Employees (FTE) 2023: 0.8 ▼ 0.2 vs 2022 (1) Unchanged	0.5 Employees (FTE) 2024: 0.5 ▼ 0.3 vs 2023 (0.8) Unchanged	0 Employees (FTE) 2025: 0 ▼ 0.5 vs 2024 (0.5) Unchanged	▼ 0.5

Key figures of APOTHEEK VANDEWALLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to APOTHEEK VANDEWALLE?

What happened at APOTHEEK VANDEWALLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Isabelle Vandewalle stepped down as director. NBB
2030 Vanram stepped down as director. NBB
Apr 30, 2026 New annual accounts for financial year 2025: loss of € 2,930. Source: NBB ↗
2024 Isabelle Vandewalle became a director. NBB
2024 Vanram became a director. NBB
Dec 21, 2000 New establishment in Gent. KBO
Dec 6, 2000 Start of the company according to the CBE. KBO

In short

From € 31,927 profit in 2022 to € 2,930 loss in 2025.

Paid € 13,719 in corporate taxes since 2022.

Best year ever: 2022, with € 31,927 profit.

On average € 142,000 of value added per employee in 2022.

Original PDFs at the National Bank ↗

Management

CARISA INVEST 80%

The stake of CARISA INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VANDEWALLE

The shares are held by CARISA INVEST (80%).

Directors

According to the 2025 annual accounts

Isabelle Vandewalle

Managing director

Also active at: Vanram, CARISA INVEST, OLYMPIA INVEST

since 2024 · until 2030

Vanram

Director · represented by Rita Ramman

since 2024 · until 2030

Shareholders

CARISA INVEST

80%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Pietersaalststraat 13

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Dokter Nick Baelde

€ 280,638 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.438.093

VAT number

BE 0473.438.093

Registered office

Sint-Pietersaalststraat 13, 9000 Gent

Names & denominations

APOTHEEK VANDEWALLE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

6 December 2000

Peppol

Active · Active since 9 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VANDEWALLE

Warning lights

Financials

What happened to APOTHEEK VANDEWALLE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions